KBTBD13

gene
On this page

Also known as hCG_1645727NEM6

Summary

KBTBD13 (kelch repeat and BTB domain containing 13, HGNC:37227) is a protein-coding gene on chromosome 15q22.31, encoding Kelch repeat and BTB domain-containing protein 13 (C9JR72). Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex.

The gene belongs to a family of genes encoding proteins containing a BTB domain and several kelch repeats. The BTB domain functions as a protein-protein interaction module, which includes an ability to self-associate or to interact with non-BTB domain-containing proteins. The kelch motif typically occurs in groups of five to seven repeats, and has been found in proteins with diverse functions. Known functions of these family members include transcription regulation, ion channel tetramerization and gating, protein ubiquitination or degradation, and cytoskeleton regulation. The exact function of this family member has yet to be determined.

Source: NCBI Gene 390594 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): nemaline myopathy 6 (Definitive, ClinGen) — +2 more curated relationships
  • Clinical variants (ClinVar): 741 total — 1 pathogenic, 2 likely-pathogenic
  • Phenotypes (HPO): 55
  • MANE Select transcript: NM_001101362

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:37227
Approved symbolKBTBD13
Namekelch repeat and BTB domain containing 13
Location15q22.31
Locus typegene with protein product
StatusApproved
AliaseshCG_1645727, NEM6
Ensembl geneENSG00000234438
Ensembl biotypeprotein_coding
OMIM613727
Entrez390594

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000432196

RefSeq mRNA: 1 — MANE Select: NM_001101362 NM_001101362

CCDS: CCDS45281

Canonical transcript exons

ENST00000432196 — 1 exons

ExonStartEnd
ENSE000017241916507674665079948

Expression profiles

Bgee: expression breadth broad, 47 present calls, max score 86.19.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0312 / max 10.8695, expressed in 19 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1472190.031219

Top tissues by expression

120 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099186.19gold quality
hindlimb stylopod muscleUBERON:000425283.10gold quality
skeletal muscle tissueUBERON:000113481.93gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047379.12silver quality
apex of heartUBERON:000209876.88gold quality
muscle of legUBERON:000138374.06gold quality
gastrocnemiusUBERON:000138872.81gold quality
heart left ventricleUBERON:000208471.05gold quality
muscle tissueUBERON:000238569.65gold quality
popliteal arteryUBERON:000225066.62gold quality
tibial arteryUBERON:000761066.60gold quality
heartUBERON:000094866.22gold quality
right atrium auricular regionUBERON:000663165.77gold quality
descending thoracic aortaUBERON:000234560.86gold quality
thoracic aortaUBERON:000151553.54gold quality
ascending aortaUBERON:000149652.92gold quality
left uterine tubeUBERON:000130349.27gold quality
sural nerveUBERON:001548847.76gold quality
left coronary arteryUBERON:000162644.35gold quality
fallopian tubeUBERON:000388944.20gold quality
endocervixUBERON:000045843.25gold quality
olfactory segment of nasal mucosaUBERON:000538643.24silver quality
body of uterusUBERON:000985342.87gold quality
uterine cervixUBERON:000000242.41gold quality
urinary bladderUBERON:000125542.00silver quality
bone marrow cellCL:000209241.88gold quality
right coronary arteryUBERON:000162541.82gold quality
ectocervixUBERON:001224941.81gold quality
subcutaneous adipose tissueUBERON:000219041.48gold quality
colonic epitheliumUBERON:000039741.13gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.98

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

70 targeting KBTBD13, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-23B-5P99.9866.07587
HSA-MIR-6793-5P99.9765.95758
HSA-MIR-141-3P99.9472.792421
HSA-MIR-200A-3P99.9472.682420
HSA-MIR-23A-5P99.9465.39468
HSA-MIR-9983-3P99.9471.483631
HSA-MIR-1236-3P99.9468.041695
HSA-MIR-627-3P99.9071.423316
HSA-MIR-4731-5P99.8967.232537
HSA-MIR-129-5P99.8870.263273
HSA-MIR-449299.8768.253611
HSA-MIR-383-3P99.8565.841359
HSA-MIR-76599.8468.242442
HSA-MIR-204-5P99.7971.622439
HSA-MIR-211-5P99.7971.652440
HSA-MIR-3934-3P99.7665.511351
HSA-MIR-11181-3P99.7566.382205
HSA-MIR-182799.6368.573265
HSA-MIR-516B-5P99.5666.331495
HSA-MIR-18A-3P99.5665.681092
HSA-MIR-444199.4966.563216
HSA-MIR-3692-5P99.2967.041421
HSA-MIR-4667-3P99.2665.451608
HSA-MIR-6744-3P99.2264.41972
HSA-MIR-429199.2068.882969
HSA-MIR-6852-5P99.1766.692073
HSA-MIR-4757-5P99.1264.51981
HSA-MIR-6814-5P99.0366.681273

Literature-anchored findings (GeneRIF, showing 5)

  • mutation screening led to the identification of a previously uncharacterized gene, KBTBD13, coding for a hypothetical protein and containing missense mutations that perfectly cosegregate with nemaline myopathy in the studied families (PMID:21109227)
  • these results demonstrate that KBTBD13 is a putative substrate adaptor for Cul3-RL that functions as a muscle specific ubiquitin ligase, and thereby implicate the ubiquitin proteasome pathway in the pathogenesis of KBTBD13-associated NEM. (PMID:22542517)
  • KBTBD13 is an actin-binding protein that modulates muscle kinetics. (PMID:31671076)
  • NEM6, KBTBD13-Related Congenital Myopathy: Myopathological Analysis in 18 Dutch Patients Reveals Ring Rods Fibers, Cores, Nuclear Clumps, and Granulo-Filamentous Protein Material. (PMID:33693846)
  • KBTBD13 is a novel cardiomyopathy gene. (PMID:36335629)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
danio_reriokbtbd13aENSDARG00000076449
mus_musculusKbtbd13ENSMUSG00000054978

Paralogs (54): KLHL13 (ENSG00000003096), KLHL20 (ENSG00000076321), KEAP1 (ENSG00000079999), KLHL42 (ENSG00000087448), KLHL22 (ENSG00000099910), KLHL4 (ENSG00000102271), KLHL2 (ENSG00000109466), KLHL5 (ENSG00000109790), BACH2 (ENSG00000112182), KLHL18 (ENSG00000114648), KLHL24 (ENSG00000114796), IVNS1ABP (ENSG00000116679), KLHL12 (ENSG00000117153), KLHL29 (ENSG00000119771), KBTBD7 (ENSG00000120696), KLHL7 (ENSG00000122550), KLHL31 (ENSG00000124743), KLHDC7B (ENSG00000130487), KLHL36 (ENSG00000135686), KLHL8 (ENSG00000145332), KLHL3 (ENSG00000146021), KLHL35 (ENSG00000149243), KLHL1 (ENSG00000150361), BACH1 (ENSG00000156273), KLHL40 (ENSG00000157119), KLHL10 (ENSG00000161594), KLHL21 (ENSG00000162413), KLHDC8A (ENSG00000162873), KBTBD8 (ENSG00000163376), KBTBD6 (ENSG00000165572), KLHL26 (ENSG00000167487), KLHL30 (ENSG00000168427), KBTBD2 (ENSG00000170852), KLHL6 (ENSG00000172578), KLHL15 (ENSG00000174010), KLHL38 (ENSG00000175946), KBTBD11 (ENSG00000176595), KLHDC7A (ENSG00000179023), KLHL28 (ENSG00000179454), KBTBD3 (ENSG00000182359)

Protein

Protein identifiers

Kelch repeat and BTB domain-containing protein 13C9JR72 (reviewed: C9JR72)

All UniProt accessions (1): C9JR72

UniProt curated annotations — full annotation on UniProt →

Function. Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex.

Subunit / interactions. Component of the BCR(KBTBD13) E3 ubiquitin ligase complex, at least composed of CUL3 and KBTBD13 and RBX1. Interacts with CUL3.

Subcellular location. Cytoplasm.

Tissue specificity. Expressed in skeletal muscle.

Post-translational modifications. Autoubiquitinated.

Disease relevance. Nemaline myopathy 6 (NEM6) [MIM:609273] A form of nemaline myopathy characterized by childhood onset of slowly progressive proximal muscle weakness, exercise intolerance, and slow movements with stiff muscles. Patients are unable to run or correct themselves from falling over. The disease is caused by variants affecting the gene represented in this entry.

Domain organisation. The BCB domain mediates the interaction with CUL3.

Pathway. Protein modification; protein ubiquitination.

RefSeq proteins (1): NP_001094832* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000210BTB/POZ_domDomain
IPR006652Kelch_1Repeat
IPR011333SKP1/BTB/POZ_sfHomologous_superfamily
IPR015915Kelch-typ_b-propellerHomologous_superfamily
IPR052392Kelch-BTB_domain-containingFamily

Pfam: PF00651, PF01344

UniProt features (10 total): repeat 5, sequence variant 3, chain 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-C9JR72-F190.560.76

Function

Pathways and Gene Ontology

Reactome pathways

7 pathways

IDPathway
R-HSA-8951664Neddylation
R-HSA-983168Antigen processing: Ubiquitination & Proteasome degradation
R-HSA-1280218Adaptive Immune System
R-HSA-168256Immune System
R-HSA-392499Metabolism of proteins
R-HSA-597592Post-translational protein modification
R-HSA-983169Class I MHC mediated antigen processing & presentation

MSigDB gene sets: 187 (showing top): GSE45365_NK_CELL_VS_CD8A_DC_DN, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION, REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_MULTICELLULAR_ORGANISMAL_MOVEMENT, GOBP_SKELETAL_MUSCLE_CONTRACTION, GOBP_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION, GOBP_REGULATION_OF_MUSCLE_CONTRACTION, GOBP_MUSCLE_CONTRACTION, GOBP_ACTIN_FILAMENT_ORGANIZATION, GOBP_RELAXATION_OF_MUSCLE, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GOBP_REGULATION_OF_SYSTEM_PROCESS, GOMF_ACTIN_BINDING

GO Biological Process (4): actin filament organization (GO:0007015), regulation of the force of skeletal muscle contraction (GO:0014728), protein ubiquitination (GO:0016567), relaxation of skeletal muscle (GO:0090076)

GO Molecular Function (2): actin filament binding (GO:0051015), protein binding (GO:0005515)

GO Cellular Component (2): cytosol (GO:0005829), cytoplasm (GO:0005737)

Reactome top-level categories

Rollup of top-5 pathways:

CategoryPathways
Post-translational protein modification1
Class I MHC mediated antigen processing & presentation1
Immune System1
Metabolism of proteins1
Adaptive Immune System1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
actin cytoskeleton organization1
supramolecular fiber organization1
regulation of skeletal muscle contraction by chemo-mechanical energy conversion1
protein modification by small protein conjugation1
relaxation of muscle1
actin binding1
protein-containing complex binding1
binding1
cytoplasm1
intracellular anatomical structure1

Protein interactions and networks

STRING

598 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
KBTBD13TNNT1P13805932
KBTBD13TPM2P06468897
KBTBD13TPM3P06753884
KBTBD13KLHL40Q2TBA0878
KBTBD13NEBP20929862
KBTBD13ACTA1P02568857
KBTBD13CFL2Q9Y281822
KBTBD13LMOD3Q0VAK6799
KBTBD13CUL3Q13618725
KBTBD13MYPNQ86TC9658
KBTBD13CCDC78A2IDD5620
KBTBD13MYOTQ9UBF9615
KBTBD13MYO18BQ8IUG5598
KBTBD13RYR1P21817561
KBTBD13KLHDC1Q8N7A1531

IntAct

6 interactions, top by confidence:

ABTypeScore
KBTBD13CUL3psi-mi:“MI:0915”(physical association)0.730
CUL3KBTBD13psi-mi:“MI:0407”(direct interaction)0.730
KBTBD13CUL3psi-mi:“MI:0407”(direct interaction)0.730

BioGRID (2): KBTBD13 (Proximity Label-MS), CUL3 (Affinity Capture-Western)

ESM2 similar proteins: A6NE02, A8MY62, C9JR72, D3Z7H8, D3ZU57, O09017, O15197, O19179, O95382, P0C0K6, P10588, P43136, P55203, Q02846, Q08DG4, Q15628, Q2KHV9, Q3U0S6, Q3UH93, Q5BK61, Q5U651, Q5W7P8, Q5ZMM1, Q6ZNJ1, Q6ZQA0, Q6ZVZ8, Q80ZD5, Q86WK7, Q8BH02, Q8BH83, Q8C828, Q8CIG9, Q8IUL8, Q8IYS2, Q8JGM4, Q8K2J9, Q8N239, Q8VHA6, Q91X21, Q96CD0

Diamond homologs: A0A1B8YAB1, A1YPR0, B0WWP2, B1H285, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, C9JR72, D3Z8N4, E0CZ16, G3X9X1, O15062, O88939, O93567, O95365, P28575, P41182, P41183, Q08CL3, Q08DK3, Q13105, Q16RL8, Q2M0J9, Q3UQV5, Q52KB5, Q5EXX3, Q5R7B8, Q5RDY3, Q5TC79, Q5ZI33, Q5ZKD9, Q5ZM39, Q60821

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

741 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic2
Uncertain significance464
Likely benign159
Benign35

Top pathogenic / likely-pathogenic (3)

Variant IDHGVSClassification
31062NM_001101362.3(KBTBD13):c.1222C>T (p.Arg408Cys)Pathogenic
1709118NM_001101362.3(KBTBD13):c.1170G>T (p.Lys390Asn)Likely pathogenic
31061NM_001101362.3(KBTBD13):c.1170G>C (p.Lys390Asn)Likely pathogenic

SpliceAI

50 predictions. Top by Δscore:

VariantEffectΔscore
15:65077777:TG:Tdonor_gain0.5500
15:65077778:GG:Gdonor_gain0.5500
15:65077838:C:Gdonor_gain0.5400
15:65077487:G:GAdonor_gain0.4600
15:65077987:G:Tdonor_gain0.4500
15:65077788:G:GGdonor_gain0.4300
15:65077787:A:AGdonor_gain0.4200
15:65077486:T:TAdonor_gain0.3900
15:65077986:G:GTdonor_gain0.3800
15:65077622:G:GTdonor_gain0.3700
15:65077774:TGGTG:Tdonor_gain0.3300
15:65077775:GGTGG:Gdonor_gain0.3300
15:65077778:G:GTdonor_gain0.3300
15:65077781:G:GGdonor_gain0.3300
15:65077879:T:Adonor_gain0.3300
15:65077884:C:Adonor_gain0.3300
15:65077482:G:GTdonor_gain0.3200
15:65077780:A:AGdonor_gain0.3200
15:65077886:C:Tdonor_gain0.3200
15:65078006:G:GAdonor_gain0.3200
15:65077783:ACGC:Adonor_gain0.3100
15:65078017:A:AGdonor_gain0.3100
15:65077856:G:GAdonor_gain0.3000
15:65077821:C:Gdonor_gain0.2900
15:65077880:G:GAdonor_gain0.2900
15:65078005:T:Adonor_gain0.2900
15:65078033:C:Adonor_gain0.2900
15:65077362:G:GTdonor_gain0.2700
15:65077488:G:GGdonor_gain0.2700
15:65077749:T:TAacceptor_gain0.2700

AlphaMissense

2920 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
15:65077374:T:AW187R0.992
15:65077374:T:CW187R0.992
15:65077376:G:CW187C0.992
15:65077376:G:TW187C0.992
15:65077889:C:AN358K0.992
15:65077889:C:GN358K0.992
15:65078023:T:AV403D0.992
15:65077905:T:CF364L0.991
15:65077907:C:AF364L0.991
15:65077907:C:GF364L0.991
15:65077950:T:AW379R0.989
15:65077950:T:CW379R0.989
15:65077449:T:GY212D0.988
15:65077875:T:GY354D0.988
15:65077291:C:AA159D0.987
15:65077670:G:CW285C0.987
15:65077670:G:TW285C0.987
15:65077906:T:GF364C0.987
15:65078076:T:AW421R0.987
15:65078076:T:CW421R0.987
15:65077453:T:AI213N0.986
15:65077979:C:AN388K0.986
15:65077979:C:GN388K0.986
15:65077836:A:CS341R0.985
15:65077838:C:AS341R0.985
15:65077838:C:GS341R0.985
15:65077885:G:CR357P0.984
15:65077888:A:TN358I0.984
15:65078103:T:CF430L0.984
15:65078105:C:AF430L0.984

dbSNP variants (sampled 300 via entrez): RS1000048869 (15:65075077 A>G,T), RS1000651112 (15:65075998 T>C), RS1000804949 (15:65080386 G>A), RS1001021711 (15:65075813 C>T), RS1002052042 (15:65076785 C>G,T), RS1002328838 (15:65075056 T>A), RS1002591118 (15:65075876 C>G,T), RS1002641714 (15:65077707 G>A,C), RS1002787310 (15:65079726 G>A), RS1002818615 (15:65079907 G>A), RS1003439253 (15:65074847 G>A), RS1003614549 (15:65078401 G>C), RS1004050576 (15:65078698 G>A), RS1004504480 (15:65077772 C>G,T), RS1004602137 (15:65077065 T>A,C)

Disease associations

OMIM: gene MIM:613727 | disease phenotypes: MIM:609273, MIM:161800, MIM:615083

GenCC curated gene-disease

DiseaseClassificationInheritance
nemaline myopathy 6DefinitiveAutosomal dominant
childhood-onset nemaline myopathySupportiveAutosomal dominant
hereditary peripheral neuropathyLimitedAutosomal recessive

ClinGen Gene-Disease Validity (1)

Expert-panel classifications — Definitive > Strong > Moderate > Limited > Disputed > Refuted.

DiseaseClassificationInheritance
nemaline myopathy 6DefinitiveAD

Mondo (5): nemaline myopathy 6 (MONDO:0012237), congenital myopathy 2a, typical, autosomal dominant (MONDO:0008070), colorectal cancer, susceptibility to, 12 (MONDO:0014038), childhood-onset nemaline myopathy (MONDO:0015738), hereditary peripheral neuropathy (MONDO:0020127)

Orphanet (3): Childhood-onset nemaline myopathy (Orphanet:171439), Congenital myopathy with excess of thin filaments (Orphanet:98904), Attenuated familial adenomatous polyposis (Orphanet:220460)

HPO phenotypes

55 total (30 of 55 shown, HPO-id order):

HPOTerm
HP:0000006Autosomal dominant inheritance
HP:0000218High palate
HP:0000275Narrow face
HP:0000276Long face
HP:0000316Hypertelorism
HP:0000347Micrognathia
HP:0000467Neck muscle weakness
HP:0000508Ptosis
HP:0000774Narrow chest
HP:0001265Hyporeflexia
HP:0001270Motor delay
HP:0001284Areflexia
HP:0001288Gait disturbance
HP:0001290Generalized hypotonia
HP:0001349Facial diplegia
HP:0001371Flexion contracture
HP:0001533Slender build
HP:0001561Polyhydramnios
HP:0001623Breech presentation
HP:0001638Cardiomyopathy
HP:0001761Pes cavus
HP:0001989Fetal akinesia sequence
HP:0002067Bradykinesia
HP:0002068Neuromuscular dysphagia
HP:0002312Clumsiness
HP:0002483Bulbar signs
HP:0002515Waddling gait
HP:0002650Scoliosis
HP:0002747Respiratory insufficiency due to muscle weakness
HP:0002792Reduced vital capacity

GWAS associations

0 associations (top):

MeSH disease descriptors (3)

DescriptorNameTree numbers
C579880Actin-Accumulation Myopathy (supp.)
C580202Intranuclear Rod Myopathy (supp.)
C538398Nemaline myopathy 6 (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

6 total (human), top 6 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression1
abrineincreases expression1
Benzo(a)pyrenedecreases methylation, increases methylation1
Cadmiumincreases expression1
Thiramincreases expression1
Triclosandecreases expression1

Clinical trials (associated diseases)

2 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT03211923Not specifiedUNKNOWNMuscle Relaxation in Myopathies With Positive Muscle Phenomena
NCT03278093Not specifiedUNKNOWNEffect of Orthoses and Underfoot Vibration on Balance in Neuropathy